Slow Release Naltrexone Implant vs Oral Naltrexone for Improving Treatment Outcomes in Opioid Addicted Participants with HIV: A Placebo-Controlled Randomised Trial

BACKGROUND: Untreated opioid addiction in persons with HIV is associated with poor outcome. Slow release, long-acting, implantable naltrexone may improve outcomes. METHODS: We conducted a 48-week outcome study beween July 2011 and April 2015 of opioid addicted males and females starting antiretrovir...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet HIV
Hlavní autoři: Krupitsky, Evgeny, Blokhina, Elena, Zvartau, Edwin, Verbitskaya, Elena, Lioznov, Dmitri, Yaroslavtseva, Tatiana, Palatkin, Vladimir, Vetrova, Marina, Bushara, Natalia, Burakov, Andrei, Masalov, Dmitri, Mamontova, Olga, Langleben, Daniel, Poole, Sabrina, Gross, Robert, Woody, George
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6529232/
https://ncbi.nlm.nih.gov/pubmed/30880163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3018(18)30362-X
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky